Application and therapeutic mechanism of Durvalumab and Tremelimumab monotherapy or combination in tumor treatment

Xuan Hou; Hidetoshi Kochi; Pengshan Li; Qi Shen

doi:10.1117/12.2692346

7 September 2023 Application and therapeutic mechanism of Durvalumab and Tremelimumab monotherapy or combination in tumor treatment

Xuan Hou, Hidetoshi Kochi, Pengshan Li, Qi Shen

Author Affiliations +

Proceedings Volume 12789, International Conference on Modern Medicine and Global Health (ICMMGH 2023); 1278930 (2023) https://doi.org/10.1117/12.2692346
Event: International Conference on Modern Medicine and Global Health (ICMMGH 2023), 2023, Oxford, United Kingdom

Abstract

Monoclonal antibodies (mAbs) have transformed from scientific tools to potent human therapeutics. Monoclonal antibody therapy has become an important treatment modality for cancer due to its strong specificity and remarkable curative effect. Among them, Durvalumab is a PD-L1 inhibitor. In anticipation of achieving a better clinical response with different drugs in combination therapy, the researchers decided to combine Durvalumab with the anti-CTLA-4 drug Tremelimumab. In addition, this type of immunotherapy is actively used as a novel treatment option for various cancers. This paper reviews the mechanism of action of Durvalumab and Tremelimumab in prospective randomized trials as a single or combination therapy for cancer and their applicability to different tumor types.

Citation Download Citation

Xuan Hou, Hidetoshi Kochi, Pengshan Li, and Qi Shen "Application and therapeutic mechanism of Durvalumab and Tremelimumab monotherapy or combination in tumor treatment", Proc. SPIE 12789, International Conference on Modern Medicine and Global Health (ICMMGH 2023), 1278930 (7 September 2023); https://doi.org/10.1117/12.2692346

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available